Objective: To describe the epidemiological and diagnostic profile of patients with metabolic syndrome seen in ambulatory rheumatology consultations. Materials and method: Descriptive cross-sectional study, conducted on the medical records of patients seen in outpatient clinics (Medical House France-Congo), from January 2022 to December 2023. Metabolic syndrome (MS) was defined according to NCEP/ATP III 2005 (National Cholesterol Education Program/Adult Treatment Panel). The study variables were epidemiological and diagnostic. Results: Of the 1149 patients seen during the study period, 183 (15.9%) had metabolic syndrome. The feminine gender predominated (64.5%) with a sex ratio of 0.5. The mean age was 57.1 ± 10.5 years (extremes 30 and 77 years). Metabolic syndrome was associated with osteoarticular disease in 57.4% of cases (n = 105). Of these, 62.9% were women. Their mean age was 59.5 ± 11 years. The main factors constituting metabolic syndrome were BMI (90.9%), high blood pressure (83.6%) and the dyslipidemia (58.1%). Metabolic syndrome predominated in degenerative diseases (71.4%), mainly common low back pain (44%) and knee osteoarthritis (30.6%). It was associated with inflammatory rheumatism in 28.6% of cases, in particular gout (53.3%) and rheumatoid arthritis (33.3%). Conclusion: Metabolic syndrome is frequent during rheumatic diseases seen in ambulatory rheumatology consultations. It was mainly of interest to patients seen for degenerative rheumatism.
References
[1]
Cameron, A. (2010) The Metabolic Syndrome: Validity and Utility of Clinical Definitions for Cardiovascular Disease and Diabetes Risk Prediction. Maturitas, 65, 117-121. https://doi.org/10.1016/j.maturitas.2009.11.026
[2]
Sylla, D., Kake, A., Wann, T.A., et al. (2023) Prevalence of Metabolic Syndrome in the Medical-Surgical Emergency Department of the Donka National Hospital. Open Journal of Internal Medicine, 13, 85-94.
[3]
Zimmet, P., Magliano, D., Matsuzawa, Y., Alberti, G. and Shaw, J. (2005) The Metabolic Syndrome: A Global Public Health Problem and a New Definition. JournalofAtherosclerosisandThrombosis, 12, 295-300. https://doi.org/10.5551/jat.12.295
[4]
Ellenga Mbolla, B., Monabeka, M., Kouala Landa, C., Ngamami ép Mongo, S., Makani Bassakouahou, J., Bakekolo, R., et al. (2021) Prevalence of Metabolic Syndrome in Rural Area in the Republic of the Congo. ArchivesofCardiovascularDiseasesSupplements, 13, 128-129. https://doi.org/10.1016/j.acvdsp.2020.10.269
[5]
Courties, A., Sellam, J. and Berenbaum, F. (2017) Metabolic Syndrome-Associated Osteoarthritis. CurrentOpinioninRheumatology, 29, 214-222. https://doi.org/10.1097/bor.0000000000000373
[6]
Borghi, C., Agabiti-Rosei, E., Johnson, R.J., Kielstein, J.T., Lurbe, E., Mancia, G., et al. (2020) Hyperuricaemia and Gout in Cardiovascular, Metabolic and Kidney Disease. EuropeanJournalofInternalMedicine, 80, 1-11. https://doi.org/10.1016/j.ejim.2020.07.006
[7]
Ministère de la santé et de la population (2012) République du Congo. Arrêté 12 572 /MSP/CAB/GDS/DSSS du 25 septembre 2012: Portant autorisation d’implantation et d’ouverture d’un centre médical de l’association «Assistance Médicale France Congo» à Brazzaville.
[8]
Grundy, S.M., Cleeman, J.I., Daniels, S.R., Donato, K.A., Eckel, R.H., Franklin, B.A., et al. (2005) Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation, 112, 2735-2752. https://doi.org/10.1161/circulationaha.105.169404
[9]
Martin-Du Pan, R.C. and Ruiz, J. (2008) Metabolic Syndrome: Jumble Syndrome of Obese People or Specific Entity? Which Treatment: Diet or Polypill? Revue Medical Suisse, 4, 366-373.
[10]
Fofana, H.R., Kaboré, A., Hien, H., Barro, M., Meda, I., Paré, B.C., et al. (2022) 99-Prévalence et facteurs associés au syndrome métabolique au Burkina Faso. Revue d’Épidémiologie et de Santé Publique, 70, S167. https://doi.org/10.1016/j.respe.2022.06.106
[11]
Koné, F., Gnaba, L.A., Touré, K.H., Kouassi, L., Koné, S., Acho, J.K., et al. (2024) Prevalence of Metabolic Syndrome in Type 2 Diabetic Patients in Bouaké, Ivory Coast. Médecine des Maladies Métaboliques, 18, 448-454. https://doi.org/10.1016/j.mmm.2024.05.002
[12]
Christian, G.R., Samandoulougou, A., Yaméogo, N.V., Yaméogo, A.R., Kologo, K.J., Toguyeni, J.Y., et al. (2014) Syndrome métabolique chez les patients hypertendus dans le service cardiologie du CHU Yalgado Ouedraogo de Ouagadougou, Burkina Faso. PanAfricanMedicalJournal, 19, Article No. 290. https://doi.org/10.11604/pamj.2014.19.290.4028
[13]
Courties, A., Berenbaum, F. and Sellam, J. (2019) Approche phénotypique de l’arthrose: Le cas de l’arthrose associée au syndrome métabolique. RevueduRhumatisme, 86, 249-254. https://doi.org/10.1016/j.rhum.2018.11.003
[14]
Lamini N’soundhat, N.E., Nkouala-Kidede, D.C., Omboumahou-Bakale, F.E., etal. (2019) Visceral Comorbidities Associated with Gout: About 75 Patients Followed at Brazzaville University Teaching Hospital (Congo). MaliMedical, 34, 13-16.
[15]
Sattui, S.E., Singh, J.A. and Gaffo, A.L. (2014) Comorbidities in Patients with Crystal Diseases and Hyperuricemia. RheumaticDiseaseClinicsofNorthAmerica, 40, 251-278. https://doi.org/10.1016/j.rdc.2014.01.005
[16]
Savadogo, B., Zabsonré/Tiendrébéogo, W., Kaboré, F., Nzigou, N., Abassiri, K., Nonguierma, V., et al. (2022) Prevalence of Metabolic Syndrome in Rheumatology Consultations in Sub-Saharan Africa. Rhumatologie Africaine Francophone, 3, 1-5. https://doi.org/10.62455/raf.v3i2.33
[17]
Tantayakom, P., Koolvisoot, A., Arromdee, E., Chiowchanwisawakit, P., Muangchan, C. and Katchamart, W. (2016) Metabolic Syndrome Is Associated with Disease Activity in Patients with Rheumatoid Arthritis. JointBoneSpine, 83, 563-567. https://doi.org/10.1016/j.jbspin.2015.10.016
[18]
Daouas, A., Abdelaziz, A.B., Zanina, Y., et al. (2022) Epidemiology of Metabolic Syndrome in Tunisia. HSHS 5 Study. LaTunisieMédicale, 100, 592-602.
[19]
Raharinavalona, S.A., Razanamparany, T., Raherison, R.E. and Rakotomalala, A.D.P. (2020) Prevalence of Metabolic Syndrome and Cardiovascular Risk Factors in Type 2 Diabetics Hospitalized in the Department of Endocrinology, Antananarivo. PanAfricanMedicalJournal, 36, Article No. 67. https://doi.org/10.11604/pamj.2020.36.67.15845
[20]
Malik, K.S. and Adoubi, K.A. (2019) Obesity, High Blood Pressure and Physical Activity Levels in a Black African Population. Annales de Cardiologie et d’Angéiologie, 68, 133-138. https://doi.org/10.1016/j.ancard.2018.08.017
[21]
Yoshimura, N., Muraki, S., Oka, H., Tanaka, S., Kawaguchi, H., Nakamura, K., et al. (2012) Accumulation of Metabolic Risk Factors Such as Overweight, Hypertension, Dyslipidaemia, and Impaired Glucose Tolerance Raises the Risk of Occurrence and Progression of Knee Osteoarthritis: A 3-Year Follow-Up of the ROAD Study. OsteoarthritisandCartilage, 20, 1217-1226. https://doi.org/10.1016/j.joca.2012.06.006
[22]
Lamini N’Soundhat, N.E., Salémo, P.A., Nkouala-Kidédé, C.D., Omboumahou Bakalé, E.F. and Ntsiba, H. (2016) Etiologies of Arthritis in Sub-Saharan Africa Rheumatology Practice. OpenJournalofRheumatologyandAutoimmuneDiseases, 6, 57-62. https://doi.org/10.4236/ojra.2016.63010
[23]
Choi, H.K., Ford, E.S., Li, C. and Curhan, G. (2007) Prevalence of the Metabolic Syndrome in Patients with Gout: The Third National Health and Nutrition Examination Survey. ArthritisCare&Research, 57, 109-115. https://doi.org/10.1002/art.22466
[24]
Chalès, G. and Richette, P. (2016) Obésité, hyperuricémie et goutte. RevueduRhumatismeMonographies, 83, 44-49. https://doi.org/10.1016/j.monrhu.2015.11.002
[25]
Ikama, S.M., Matingou, A.R., Makani, J., Nsounda, N.L., Mongo-Ngamami, S.F., Ellenga-Mbolla, B.F., et al. (2019) Hyperuricemia and Associated Factors during Arterial Hypertension in Brazzaville (Congo). WorldJournalofCardiovascularDiseases, 9, 236-244. https://doi.org/10.4236/wjcd.2019.93021
[26]
Angalla, A.R.L., Lamini N’soundhat, N.E., Nkouala-Kidédé, D.C., etal. (2024) Features of Rheumatoid Arthritis at the Rheumatology Clinic of the University Teaching Hospital of Brazzaville. HealthSciencesandDisease, 25, 83-88.
[27]
Bouzidi, M., Arfaoui, B., Sayhi, S., Gueddiche, N., Ajili, F. and Ben Abdelhfidh, N. (2023) Corticosteroids and Metabolic Complications in Internal Medicine. Annalesd’Endocrinologie, 84, 609. https://doi.org/10.1016/j.ando.2023.07.289
